Freedman, Joseph Stuart — Insider Profile

Insider Profile

Freedman, Joseph Stuart

🔒 Follow — get an alert on any new filing

$EPRX

Companies Filed At

Open-Market Buys (2yr)

$3.3M

Buy Value (2yr, open-market)

Mar 02, 2026

Most Recent Trade

Credibility
Score

100%

Hit Rate

+27.9%

Avg 90d Return

+28.4%

Median 90d Return

Evaluated Trades

+38.4%

Best Trade

+18.4%

Worst Trade

Hit rate and returns are based on 19 open-market buys with evaluable 90-day outcomes. Score reflects historical conviction, not a guarantee of future performance. This insider ranks among the highest-credibility tracked on Form55.

Cross-Company Track Record

100%

Hit Rate · 90d

+16.5%

Median Alpha · 90d

Closed Buys Evaluated

100%

Beat XIU

All-insider base rate: 59% hit rate · +1.3% mean alpha (n=11504)

cluster buyer high frequency size concentrated

Entry: closing price on SEDI filing date (point-in-time). Exit: 90 calendar days later. Alpha vs XIU.TO (iShares TSX 60). Closed trades only. Not investment advice.

Research 16 closed buys with individual return outcomes available on the Research plan.

Political Donations · Elections Canada

$2K in individual political contributions across 1 donation (2021–2021).

Date	Party	Recipient	Amount
2021-08-25	Conservative Party of Canada	York Centre Conservative Association	$2K

Source: Elections Canada public contribution records (individual donations only; corporate political donations have been banned federally since 2007). Matched to this insider by name — shown for transparency, not a claim of wrongdoing and not a Confluence Score input.

Date	Company	Role	Nature	Dir.	Shares	Price	Value	Score
Mar 02, 2026	$EPRX Eupraxia Pharmaceuticals	—	Exercise	Buy	20,000	$3.00	$60K	62
Mar 02, 2026	$EPRX Eupraxia Pharmaceuticals	—	Exercise	Buy	150,000	$3.00	$450K	62
Mar 02, 2026	$EPRX Eupraxia Pharmaceuticals	—	Exercise	Sell	170,000	$3.00	$510K	62
Sep 26, 2025	$EPRX Eupraxia Pharmaceuticals	—	Ownership Chg	Sell	1,500	—	—	62
Sep 26, 2025	$EPRX Eupraxia Pharmaceuticals	—	Ownership Chg	Buy	1,500	—	—	62
Sep 26, 2025	$EPRX Eupraxia Pharmaceuticals	—	Other	Sell	3,500	—	—	62
Sep 24, 2025	$EPRX Eupraxia Pharmaceuticals	—	Open Market	Buy	6,573	$5.50	$36K	62
Sep 24, 2025	$EPRX Eupraxia Pharmaceuticals	—	Open Market	Buy	61,350	$5.50	$337K	62
Sep 24, 2025	$EPRX Eupraxia Pharmaceuticals	—	Open Market	Buy	166,290	$5.50	$915K	62
Sep 24, 2025	$EPRX Eupraxia Pharmaceuticals	—	Open Market	Buy	282,627	$5.50	$1.6M	62
Sep 24, 2025	$EPRX Eupraxia Pharmaceuticals	—	Open Market	Buy	13,145	$5.50	$72K	62
Sep 24, 2025	$EPRX Eupraxia Pharmaceuticals	—	Open Market	Buy	13,145	$5.50	$72K	62
Sep 24, 2025	$EPRX Eupraxia Pharmaceuticals	—	Open Market	Buy	13,145	$5.50	$72K	62
Jun 18, 2025	$EPRX Eupraxia Pharmaceuticals	—	Open Market	Buy	5,000	$5.94	$30K	62
Jun 17, 2025	$EPRX Eupraxia Pharmaceuticals	—	Open Market	Buy	5,000	$5.68	$28K	62
Jun 16, 2025	$EPRX Eupraxia Pharmaceuticals	—	Open Market	Buy	2,000	$5.28	$11K	62
Jun 16, 2025	$EPRX Eupraxia Pharmaceuticals	—	Open Market	Buy	1,400	$5.29	$7K	62
Jun 16, 2025	$EPRX Eupraxia Pharmaceuticals	—	Open Market	Buy	5,000	$5.32	$27K	62
Jun 16, 2025	$EPRX Eupraxia Pharmaceuticals	—	Open Market	Buy	5,000	$5.34	$27K	62
Jun 16, 2025	$EPRX Eupraxia Pharmaceuticals	—	Open Market	Buy	5,000	$5.35	$27K	62
Jun 16, 2025	$EPRX Eupraxia Pharmaceuticals	—	Open Market	Buy	5,000	$5.45	$27K	62
Jun 06, 2025	$EPRX Eupraxia Pharmaceuticals	—	Open Market	Buy	20,000	$5.00	$100K	62
Mar 25, 2025	$EPRX Eupraxia Pharmaceuticals	—	Comp. Grant	Buy	45,000	$5.14	$231K	62
Dec 10, 2024	$EPRX Eupraxia Pharmaceuticals	—	Comp. Grant	Buy	90,000	$4.66	$419K	62
Oct 31, 2024	$EPRX Eupraxia Pharmaceuticals	—	Other	Sell	—	—	—	62
Oct 31, 2024	$EPRX Eupraxia Pharmaceuticals	—	Other	Sell	—	—	—	62
Oct 31, 2024	$EPRX Eupraxia Pharmaceuticals	—	Other	Sell	1,006,100	—	—	62

Muted rows are plan purchases, compensation grants, or DRIP — not open-market. Confluence Scores reflect the company's current score, not the score at time of trade.